DISASTER RECOVERY FACT SHEET
Methicillin-Resistant Staphylococcus aureus (MRSA) Information for Clinicians
General Information
- Though once found almost exclusively in healthcare settings, strains of Staphylococcus aureus resistant to beta-lactam antibiotics (MRSA) are increasingly common as a cause of skin and soft tissue infections in patients who have no previous contact with healthcare. These strains are sometimes referred to as “community-associated MRSA”.
Clinical Features
- MRSA infections often begin as skin or soft tissue lesions such as a boil or abscess and/or cellulitis.
- Patients frequently report a lesion that looks to them like a “spider bite.”
- Other more severe manifestations such as bloodstream infections or pneumonia are less common.
Diagnosis
- Obtain material for culture from skin lesions such as swab of pus or drainage.
- Use microbiologic culture results to guide appropriate antibiotic selection.
Treatment
- Mild (afebrile, looks healthy) to Moderate (febrile, appears ill) Skin Infections
- First-line treatment for mild abscesses is incision and drainage.
- If antibiotic treatment is clinically indicated, it should be guided by the susceptibility profile of the organism.
- If MRSA, avoid beta-lactam antibiotics (e.g., cephalexin).
- Most MRSA in community settings have been susceptible to trimethoprim-sulfamethoxazole and doxycycline. Clindamycin is also an option, but some isolates that appear susceptible to clindamycin have inducible resistance. Clindamycin susceptibility should be confirmed with a “D-test”.
- Severe Infection (e.g., appears toxic, vital signs unstable, sepsis-syndrome)
- Intravenous therapy for MRSA is preferred in these cases. Vancomycin remains a first-line therapy for MRSA.
- Final therapy based on results of culture and susceptibility testing.
- Consult with infectious disease and critical care specialist.
Infection Control Recommendations
- Use standard precautions
- Perform hand hygiene (handwashing or using alcohol hand gel)
- After touching blood, body fluids, secretions, excretions, and contaminated items, whether or not gloves are worn.
- Between patients.
- When moving from a contaminated body site to a clean site on the same patient.
- Wear gloves when managing wounds/
- Wear gown, and mask/eye protection or face shield for procedures that are likely to generate splashes or sprays of blood, body fluids, secretions, or excretions.
- Clean surfaces of exam rooms with commercial disinfectant or a 1:100 solution of diluted bleach (1 tablespoon bleach in 1 quart water).
Prevention Messages for Patients
- Keep wounds and lesions covered with clean, dry bandages.
- Wash hands or use alcohol hand gels after touching infected skin or bandages.
- Avoid sharing personal items (e.g., towels, washcloths, razors).
- Be on the lookout for similar infections in family members and/or close contacts.
- Page last updated September 21, 2005
- Content source: CDC Emergency Communication System (ECS), Division of Health Communication and Marketing (DHCM), National Center for Health Marketing (NCHM)
Get email updates
To receive email updates about this page, enter your email address:
Contact Us:
- Centers for Disease Control and Prevention
1600 Clifton Rd
Atlanta, GA 30333 - 800-CDC-INFO
(800-232-4636)
TTY: (888) 232-6348
24 Hours/Every Day - cdcinfo@cdc.gov